SK286378B6 - Použitie kompozície, ktorej účinnou zložkou je docetaxel alebo jeho hydrát, na prípravu liečiva na použitie na liečenie hepatocelulárneho karcinómu - Google Patents

Použitie kompozície, ktorej účinnou zložkou je docetaxel alebo jeho hydrát, na prípravu liečiva na použitie na liečenie hepatocelulárneho karcinómu Download PDF

Info

Publication number
SK286378B6
SK286378B6 SK271-2002A SK2712002A SK286378B6 SK 286378 B6 SK286378 B6 SK 286378B6 SK 2712002 A SK2712002 A SK 2712002A SK 286378 B6 SK286378 B6 SK 286378B6
Authority
SK
Slovakia
Prior art keywords
docetaxel
cells
treatment
paclitaxel
pmol
Prior art date
Application number
SK271-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK2712002A3 (en
Inventor
Chin-Wen Chi
Heng-Liang Lin
Tsung-Yun Liu
Wing-Yiu Lui
Gar-Yang Chau
Original Assignee
Aventis Pharma S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S. A. filed Critical Aventis Pharma S. A.
Publication of SK2712002A3 publication Critical patent/SK2712002A3/sk
Publication of SK286378B6 publication Critical patent/SK286378B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SK271-2002A 1999-08-31 2000-08-29 Použitie kompozície, ktorej účinnou zložkou je docetaxel alebo jeho hydrát, na prípravu liečiva na použitie na liečenie hepatocelulárneho karcinómu SK286378B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920548.6A GB9920548D0 (en) 1999-08-31 1999-08-31 Treatment of hepatocellular carcinoma
PCT/EP2000/008782 WO2001015675A2 (en) 1999-08-31 2000-08-29 Use of docetaxel for treating hepatocellular carcinoma

Publications (2)

Publication Number Publication Date
SK2712002A3 SK2712002A3 (en) 2002-07-02
SK286378B6 true SK286378B6 (sk) 2008-08-05

Family

ID=10860081

Family Applications (1)

Application Number Title Priority Date Filing Date
SK271-2002A SK286378B6 (sk) 1999-08-31 2000-08-29 Použitie kompozície, ktorej účinnou zložkou je docetaxel alebo jeho hydrát, na prípravu liečiva na použitie na liečenie hepatocelulárneho karcinómu

Country Status (34)

Country Link
US (2) US20030158249A1 (no)
EP (1) EP1214061B1 (no)
JP (1) JP4866522B2 (no)
KR (1) KR100670416B1 (no)
CN (1) CN1174748C (no)
AT (1) ATE269700T1 (no)
AU (1) AU777583B2 (no)
BG (1) BG65913B1 (no)
BR (1) BR0013625A (no)
CA (1) CA2382294C (no)
CZ (1) CZ301378B6 (no)
DE (1) DE60011794T2 (no)
DK (1) DK1214061T3 (no)
EA (1) EA004804B1 (no)
EE (1) EE05124B1 (no)
ES (1) ES2218223T3 (no)
GB (1) GB9920548D0 (no)
HK (1) HK1048944B (no)
HR (1) HRP20020171A2 (no)
HU (1) HU228861B1 (no)
IL (2) IL147489A0 (no)
ME (1) MEP7809A (no)
MX (1) MXPA02002041A (no)
NO (1) NO328527B1 (no)
NZ (1) NZ517604A (no)
PL (1) PL212612B1 (no)
PT (1) PT1214061E (no)
RS (1) RS50148B (no)
SI (1) SI1214061T1 (no)
SK (1) SK286378B6 (no)
TW (1) TW589180B (no)
UA (1) UA72927C2 (no)
WO (1) WO2001015675A2 (no)
ZA (1) ZA200201408B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1268619C (zh) * 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
EP1947094A3 (en) * 2003-12-12 2009-02-18 Quiral Quimica Do Brasil Process for the preparation of taxane derivatives
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use
TWI417114B (zh) 2005-08-31 2013-12-01 Abraxis Bioscience Llc 具有增強穩定性之弱水溶性藥物之組合物及其製備方法
CN101291658B (zh) 2005-08-31 2014-04-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US20080081051A1 (en) * 2006-09-28 2008-04-03 Robert Sabin Method of manufacturing anti-tumor and anti-viral compositions
US20080262078A1 (en) * 2007-04-20 2008-10-23 Namdeo Alok B Pharmaceutical Compositions
FR2917088B1 (fr) * 2007-06-08 2009-09-04 Aventis Pharma Sa Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers
HUE027749T2 (en) 2010-03-26 2016-10-28 Abraxis Bioscience Llc Methods of treating hepatocellular carcinoma
MX341082B (es) * 2010-05-03 2016-08-08 Teikoku Pharma Usa Inc Formulaciones de pro-emulsion de taxano no acuosas y metodos para hacer y usar las mismas.
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
JO3685B1 (ar) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
WO2016134066A1 (en) * 2015-02-17 2016-08-25 Mallinckrodt Llc Modified docetaxel liposome formulations and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
WO1994016693A1 (en) * 1993-01-19 1994-08-04 Warner-Lambert Company Stable oral ci-981 formulation and process of preparing same
US5801029A (en) * 1993-02-16 1998-09-01 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
FR2718963B1 (fr) * 1994-04-25 1996-05-24 Rhone Poulenc Rorer Sa Nouvelle composition pharmaceutique à base de taxoïdes.
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
US5968972A (en) 1995-10-26 1999-10-19 Baker Norton Pharmaceuticals, Inc. Method for increasing the oral bioactivity of pharmaceutical agents
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
FR2742751B1 (fr) * 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0954283B1 (en) * 1996-12-30 2007-03-21 Battelle Memorial Institute Use of a non-encapsulated anticancer drug for the preparation of a formulation for treating neoplasms by inhalation
US6503893B2 (en) * 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
CN100462066C (zh) * 1997-06-27 2009-02-18 美国生物科学有限公司 药剂的新制剂及其制备和应用方法
JP3775780B2 (ja) * 1997-09-18 2006-05-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 薬剤の経口的バイオアベイラビリテイを向上させるための縮合イミダゾール誘導体
US6576660B1 (en) * 1997-10-31 2003-06-10 Arch Development Corporation Methods and compositions for regulation of 5-α-reductase activity
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
WO2000038730A2 (en) * 1998-12-23 2000-07-06 G.D. Searle & Co. Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
KR20100023059A (ko) * 2005-12-13 2010-03-03 테바 파마슈티컬 인더스트리즈 리미티드 아토바스타틴 헤미칼슘의 결정형 및 이의 제조 방법

Also Published As

Publication number Publication date
YU11402A (sh) 2005-07-19
NZ517604A (en) 2004-04-30
ME00624B (me) 2011-12-20
RS50148B (sr) 2009-05-06
BG65913B1 (bg) 2010-05-31
ATE269700T1 (de) 2004-07-15
AU7516800A (en) 2001-03-26
EA200200313A1 (ru) 2002-08-29
EP1214061A2 (en) 2002-06-19
HK1048944A1 (en) 2003-04-25
JP2003508427A (ja) 2003-03-04
DE60011794T2 (de) 2005-07-14
CN1372466A (zh) 2002-10-02
MEP7809A (en) 2011-12-20
MXPA02002041A (es) 2002-08-20
US20080045584A1 (en) 2008-02-21
HUP0203197A3 (en) 2005-01-28
CN1174748C (zh) 2004-11-10
NO20020829D0 (no) 2002-02-20
GB9920548D0 (en) 1999-11-03
ES2218223T3 (es) 2004-11-16
CA2382294A1 (en) 2001-03-08
DE60011794D1 (de) 2004-07-29
DK1214061T3 (da) 2004-11-01
WO2001015675A3 (en) 2001-09-20
AU777583B2 (en) 2004-10-21
PL353198A1 (en) 2003-11-03
IL147489A (en) 2006-06-11
NO20020829L (no) 2002-02-20
EA004804B1 (ru) 2004-08-26
KR20020060166A (ko) 2002-07-16
TW589180B (en) 2004-06-01
ZA200201408B (en) 2003-07-30
UA72927C2 (uk) 2005-05-16
SI1214061T1 (en) 2004-12-31
PL212612B1 (pl) 2012-10-31
HRP20020171A2 (en) 2004-02-29
WO2001015675A2 (en) 2001-03-08
NO328527B1 (no) 2010-03-08
CZ2002739A3 (cs) 2002-06-12
BG106460A (bg) 2002-09-30
EE200200087A (et) 2003-04-15
HU228861B1 (hu) 2013-06-28
SK2712002A3 (en) 2002-07-02
EE05124B1 (et) 2009-02-16
EP1214061B1 (en) 2004-06-23
KR100670416B1 (ko) 2007-01-17
US20030158249A1 (en) 2003-08-21
HK1048944B (zh) 2005-04-22
CZ301378B6 (cs) 2010-02-03
PT1214061E (pt) 2004-09-30
JP4866522B2 (ja) 2012-02-01
HUP0203197A2 (hu) 2003-01-28
BR0013625A (pt) 2002-05-14
CA2382294C (en) 2008-06-03
IL147489A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
US20080045584A1 (en) Use of Docetaxel for Treating Hepatocellular Carcinoma
KR102255753B1 (ko) 뮤신 관련 질환의 치료
CN113797343A (zh) 使用辅酶q10联合疗法治疗癌症
CN113318110A (zh) 一种csf-1r激酶抑制剂的用途
US20150110774A1 (en) S100 protein inhibitors for treating leukemia
US5891864A (en) Anti-cancer compositions
CN109568313B (zh) 一种抗肿瘤联合用药物及其在制备抗癌药物中的应用
US8580847B2 (en) Antrocin containing pharmaceutical compositions for inhibiting cancer cells
US20220211663A1 (en) Nano co-delivery of quercetin and alantolactone promotes anti-tumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer
CN115381956B (zh) 一种治疗癌症的药物组合物及其用途
EP4331614A1 (en) Use of medicament in treatment of tumor disease
KR101378484B1 (ko) 알부민 결합성 약물의 안전성 및 효능을 증가시키는 방법및 조성물
US7671038B1 (en) Method of therapeautic treatments including human immunodeficiency virus (HIV) disease and other conditions in a human host by administering adenine nucleotides
JPH11209283A (ja) 抗癌剤
JP4768909B2 (ja) トポイソメラーゼ阻害剤
JPH02235813A (ja) 抗腫瘍剤
US20230092728A1 (en) Compounds, pharmaceutical formulations, and methods for treatment of cancer
RU2549430C2 (ru) Фармацевтическая композиция на основе производного трииндолилметана в качестве противоопухолевого средства

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20150829